Supplements for Cardiovascular Risk Factors
2 supplements with research evidence for Cardiovascular Risk Factors
What the Research Shows
Research regarding supplements for cardiovascular risk factors shows different levels of scientific support. Nattokinase has moderate evidence, as systematic reviews and meta-analyses suggest it may influence various markers associated with cardiovascular health. In contrast, there is insufficient evidence to confirm the effectiveness of Reishi for managing these risk factors. Although meta-analyses have explored the use of Ganoderma lucidum, the current research does not provide enough certainty to draw definitive conclusions.
AI-generated overview based on research evidence. Not medical advice.
Evidence-Backed Supplements
Supplements ranked by evidence strength: strong = Tier-A meta-analyses/guidelines, moderate = Tier-B RCTs/systematic reviews, weak = Tier-C observational.
| Supplement | Evidence Strength | Research Sources | Products on Market |
|---|---|---|---|
| Nattokinase Best products → | moderate | 0 | 124 |
| Reishi Best products → | insufficient | 0 | 291 |
This page is generated from AI-analyzed evidence summaries. Evidence strength ratings are based on the quality and quantity of available research, not guaranteed effectiveness. Always consult a healthcare provider before using supplements for any health condition.
See our Editorial Policy for methodology and Medical Disclaimer.
Frequently Asked Questions
What supplements have the strongest evidence for Cardiovascular Risk Factors?
No supplements currently have strong (Tier-A) evidence for Cardiovascular Risk Factors. The best-supported supplements are: Nattokinase (moderate evidence), Reishi (insufficient evidence).
How many supplements have been studied for Cardiovascular Risk Factors?
2 supplements have been researched in connection with Cardiovascular Risk Factors, with varying levels of evidence strength. See the table above for details on each supplement's evidence rating and number of research sources.